Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$922M Buy
2,600,597
+387,713
+18% +$103M 0.56% 32
2026
Q1
$335M Buy
2,212,884
+2,162,503
+4,292% +$262M 0.25% 75
2025
Q4
$5.51M Buy
50,381
+11,793
+31% +$1.71M ﹤0.01% 753
2025
Q3
$5.46M Buy
38,588
+22,733
+143% +$3.31M 0.01% 734
2025
Q2
$2.56M Buy
15,855
+1,214
+8% +$151K ﹤0.01% 927
2025
Q1
$1.56M Buy
14,641
+4,880
+50% +$681K ﹤0.01% 986
2024
Q4
$1.2M Buy
9,761
+7,047
+260% +$994K ﹤0.01% 1008
2024
Q3
$387K Buy
+2,714
New +$386K ﹤0.01% 1118

Other funds holding ARM

VanEck Associates's ARM Position: Q2 2026 in Review

VanEck Associates increased its Arm (ARM) stake by 18% in Q2 2026, buying an estimated $103M and bringing the position to 2,600,597 shares worth $922M. The position accounts for 0.56% of the portfolio, ranked #32.

VanEck Associates first reported a position in ARM in Q3 2024 and has held it in 8 quarters since. 956 funds tracked by Wall St. Rank hold ARM as of Q2 2026.

  • VanEck Associates held 2,600,597 shares of Arm worth $922M as of Q2 2026.
  • VanEck Associates bought 387,713 Arm shares in Q2 2026, an estimated $103M.
  • Arm made up 0.56% of VanEck Associates's portfolio in Q2 2026, its #32 holding.
  • VanEck Associates first reported a position in Arm in Q3 2024 and has held it in 8 quarters since.
  • 956 funds tracked by Wall St. Rank held Arm as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.